Strategic Partnerships US Endovascular partners directly with manufacturers and pursues programs like RePRO to reduce costs across US, European, and Latin American markets. This signals opportunities to position cost-effective supply solutions and leverage their direct-from-manufacturer strengths in conversations with outpatient labs, ASCs, and hospitals.

Cost-Effective Platform Fully online purchasing platform targets outpatient labs, ASCs, and hospitals with high-value devices. Sales outreach can emphasize streamlined procurement, broad product portfolio, and potential savings on PTA balloons, reprocessed IVUS, and related devices.

Growth via Partnerships Recent collaboration with CoSo Health to reach the U.S. market indicates a pathway for joint go-to-market strategies and expanded channel distribution. Explore alliance opportunities to access broader customer networks and accelerate market penetration.

Niche Market Focus Small company scale with <$1M revenue suggests a high CTR for targeted, high-margin wins in coronary and peripheral technology. Propose pilot programs, bundled offerings, and reimbursement-ready solutions to win first deployments and build reference sites.

Competitive Positioning Positioning against large medtech players by emphasizing cost efficiency, supply-chain transparency, and a broad, accessible portfolio can attract mid-market hospitals and ASCs seeking alternatives to big incumbents. Tailor messaging around value, reliability, and faster procurement.